| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/07/2005 | WO2005061704A1 Preventive/remedy for cancer |
| 07/07/2005 | WO2005061694A1 Drug testing system with bio-artificial liver |
| 07/07/2005 | WO2005061692A1 Microarray-based analysis of rheumatoid arthritis markers |
| 07/07/2005 | WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | WO2005061542A2 Detection of cd20 in transplant rejection |
| 07/07/2005 | WO2005061541A1 Anti-igf-i receptor antibody |
| 07/07/2005 | WO2005061537A2 Squamous cell carcinoma antigens and use thereof |
| 07/07/2005 | WO2005061532A1 Pathogenic infection detection compositions and methods |
| 07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
| 07/07/2005 | WO2005061075A1 Magnetic separation apparatus and methods |
| 07/07/2005 | WO2005061013A1 Personal care products with visual indicator of vaginitis |
| 07/07/2005 | WO2005060951A2 Anti-neoplastic agents, combination therapies and related methods |
| 07/07/2005 | WO2005060725A2 Nucleic acid amplification methods |
| 07/07/2005 | WO2005060722A2 Modulation of immune system function by modulation of polypeptide arginine methyltransferases |
| 07/07/2005 | WO2005060721A2 Manipulation of rna interference through modulation of armitage activity |
| 07/07/2005 | WO2005060713A2 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions |
| 07/07/2005 | WO2005060675A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/07/2005 | WO2005060661A2 Methods and materials for assessing prostate cancer therapies |
| 07/07/2005 | WO2005060656A2 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy |
| 07/07/2005 | WO2005060627A2 Methods of assessing the risk of non-traumatic bone fracture |
| 07/07/2005 | WO2005060626A2 Metal ion mediated fluorescence superquenching assays, kits and reagents |
| 07/07/2005 | WO2005060608A2 Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing |
| 07/07/2005 | WO2005060517A2 Genes commonly regulated by different classes of antidepressants |
| 07/07/2005 | WO2005060479A2 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005052182A3 A method of analyzing plasma membrane protein content of cells |
| 07/07/2005 | WO2005050225A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84) |
| 07/07/2005 | WO2005050198A3 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 07/07/2005 | WO2005050165A3 Rapid sample analysis and storage devices and methods of use |
| 07/07/2005 | WO2005047482A3 Real time electronic cell sensing systems and applications for cell-based assays |
| 07/07/2005 | WO2005043162A8 Method for distinguishing mll-ptd-positive aml from other aml subtypes |
| 07/07/2005 | WO2005043125A3 A non-fluorescent, non-enzymatic, chemiluminescent aqueous assay |
| 07/07/2005 | WO2005042770A3 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
| 07/07/2005 | WO2005041212A3 Use of conductive or semi-conductive polymers in chemical sensors for detecting nitro compounds |
| 07/07/2005 | WO2005040806A3 Use of protein asc as a marker for breast cancer |
| 07/07/2005 | WO2005038043A3 Methods of detecting poly (adp-ribose) polymerase and other nad+utilizing enzymes |
| 07/07/2005 | WO2005038006A3 Chimeric metabotropic glutamate receptors and uses thereof |
| 07/07/2005 | WO2005037052A3 Binding assay with labelled bispidine variant |
| 07/07/2005 | WO2005035720A3 Methods and use of binding components for improving assay specificity |
| 07/07/2005 | WO2005033333A3 Methods and compositions for the diagnosis of cancer |
| 07/07/2005 | WO2005033284A3 Compositions and methods for gene expression |
| 07/07/2005 | WO2005031365A3 Rapid determination of hepatocyte growth factor (hgf) in the body fluids |
| 07/07/2005 | WO2005031345A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
| 07/07/2005 | WO2005030269A8 Endotoxin-nonresponsive model animal |
| 07/07/2005 | WO2005028640A8 Method for isolating hepatocytes |
| 07/07/2005 | WO2005027719A3 Methods and systems for identifying predisposition to the placebo effect |
| 07/07/2005 | WO2005026724A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a5 (slc22a5) |
| 07/07/2005 | WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 07/07/2005 | WO2005020785A3 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 07/07/2005 | WO2005019419A3 Co-detection of single polypeptide and polynucleotide molecules |
| 07/07/2005 | WO2005003821A3 Phase change sensor |
| 07/07/2005 | WO2005003780A3 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 4 (snsr4) |
| 07/07/2005 | WO2005003779A3 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 3 (snsr3) |
| 07/07/2005 | WO2005001138A3 Breast cancer survival and recurrence |
| 07/07/2005 | WO2004111612A3 Porous nanostructures and methods involving the same |
| 07/07/2005 | WO2004110356A3 Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity |
| 07/07/2005 | WO2004103149A3 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 07/07/2005 | WO2004099783A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) |
| 07/07/2005 | WO2004099368A3 Methods for detecting intracellular defensins in various leukocyte subpopulations |
| 07/07/2005 | WO2004096020A3 Method for detection and characterization of pre-malignant transformation |
| 07/07/2005 | WO2004095033A3 Compositions and methods for accurate early pregnancy diagnosis in ungulates |
| 07/07/2005 | WO2004084830A3 Method for treating alzheimer’s dementia |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004078909A3 Identification of antigen epitopes |
| 07/07/2005 | WO2004072296A3 Compositions for modulating immune cell activity and methods for detection thereof |
| 07/07/2005 | WO2004072258A3 Stimuli-responsive polymer conjugates and related methods |
| 07/07/2005 | WO2004062570A3 Apparatus and method to measure platelet contractility |
| 07/07/2005 | WO2004059306A8 A cantilever sensor using both the longitudinal and the transversal piezoresistive coefficients |
| 07/07/2005 | WO2004052290A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 07/07/2005 | WO2004044586A8 Nanotube-based electronic detection of biological molecules |
| 07/07/2005 | WO2004042353A8 Identifying therapeutic compounds based on their physical-chemical properties |
| 07/07/2005 | WO2004042032A3 Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| 07/07/2005 | WO2004031768A3 Method for screening modulators of mitochondrial functioning |
| 07/07/2005 | WO2004003233A8 Methods to assess quality of microarrays |
| 07/07/2005 | WO2003103593A3 Secretases related to alzheimer's dementia |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders |
| 07/07/2005 | US20050149272 Method for sequencing polynucleotides |
| 07/07/2005 | US20050149271 Methods and apparatus for complex gentics classification based on correspondence anlysis and linear/quadratic analysis |
| 07/07/2005 | US20050149269 Browsable database for biological use |
| 07/07/2005 | US20050149268 Methods of data analysis using ranks |
| 07/07/2005 | US20050148848 Stereo display of tube-like structures and improved techniques therefor ("stereo display") |
| 07/07/2005 | US20050148838 Pharmaceutical discovery and development |
| 07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
| 07/07/2005 | US20050148536 Methods for treating and preventing insulin resistance and related disorders |
| 07/07/2005 | US20050148532 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148101 Immobilized colloid particles; automatic determination of changes in colloids using electromagnetic radiation or absorption |
| 07/07/2005 | US20050148100 Methods and devices for using Raman-active probe constructs to assay biological samples |
| 07/07/2005 | US20050148099 Immunoassay apparatus and immunoassay method |
| 07/07/2005 | US20050148098 Methods for using raman spectroscopy to obtain a protein profile of a biological sample |
| 07/07/2005 | US20050148097 Instruments for detecting low-molecular weight substance |
| 07/07/2005 | US20050148096 Methods for detecting pregnancy |
| 07/07/2005 | US20050148091 Using multicompartment apparatus for detecting preferential compounds in solution; drug screening; water quality testing |
| 07/07/2005 | US20050148090 Rapid assay, method and system for detecting biowarfare agents |
| 07/07/2005 | US20050148087 Isobarically labeled analytes and fragment ions derived therefrom |
| 07/07/2005 | US20050148086 Fluorescent sensor for phosphate ion and phosphorylated peptide |
| 07/07/2005 | US20050148085 Method and a system for detecting and optinally isolating a rare event particle |
| 07/07/2005 | US20050148073 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |